Observational studyThe Lancet. Infectious diseases2023

Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.

Neil R Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.